Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials

Background: Many placebo-controlled trials have demonstrated the efficacy of individual pharmacotherapies approved for smoking cessation. However, few direct or indirect comparisons of such interventions have been conducted. We performed a meta-analysis to compare the treatment effects of 7 approved pharmacologic interventions for smoking cessation. Methods: We searched the US Centers for Disease Control and Prevention's Tobacco Information and Prevention database as well as MEDLINE, EMBASE and the Cochrane Library for published reports of placebo-controlled, double-blind randomized controlled trials of pharmacotherapies for smoking cessation. We included studies that reported biochemically validated measures of abstinence at 6 and 12 months. We used a hierarchical Bayesian random-effects model to summarize the results for each intervention. Results: We identified 70 published reports of 69 trials involving a total of 32 908 patients. Six of the 7 pharmacotherapies studied were found to be more efficacious than placebo: varenicline (odds ratio [OR] 2.41, 95% credible interval [CrI] 1.91–3.12), nicotine nasal spray (OR 2.37, 95% CrI 1.12–5.13), bupropion (OR 2.07, 95% CrI 1.73–2.55), transdermal nicotine (OR 2.07, 95% CrI 1.69–2.62), nicotine tablet (OR 2.06, 95% CrI 1.12–5.13) and nicotine gum (OR 1.71, 95% CrI 1.35–2.21). Similar results were obtained regardless of which measure of abstinence was used. Although the point estimate favoured nicotine inhaler over placebo (OR 2.17), these results were not conclusive because the credible interval included unity (95% CrI 0.95–5.43). When all 7 interventions were included in the same model, all were more efficacious than placebo. In our analysis of data from the varenicline trials that included bupropion control arms, we found that varenicline was superior to bupropion (OR 2.18, 95% CrI 1.09–4.08). Interpretation: Varenicline, bupropion and the 5 nicotine replacement therapies were all more efficacious than placebo at promoting smoking abstinence at 6 and 12 months.

[1]  R. Perera,et al.  Nicotine replacement therapy for smoking cessation (Review) , 2008 .

[2]  D. Sherrill,et al.  Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release bupropion for adolescent smoking cessation. , 2007, Archives of pediatrics & adolescent medicine.

[3]  C. la Vecchia,et al.  A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care. , 2007, Archives of internal medicine.

[4]  M. Ussher,et al.  Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation. , 2007, The Cochrane database of systematic reviews.

[5]  Hong-Jun Cho,et al.  A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers. , 2007, Clinical therapeutics.

[6]  T. Ishibashi,et al.  Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. , 2007, Clinical therapeutics.

[7]  R. Anziano,et al.  Long-term fatty fish consumption and renal cell carcinoma incidence in women. , 2006, JAMA.

[8]  R. Anziano,et al.  Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. , 2006, Archives of internal medicine.

[9]  Jason Gong,et al.  Efficacy of Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation A Randomized Controlled Trial , 2006 .

[10]  David Gonzales,et al.  Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial , 2006 .

[11]  J. Foulds.  The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline , 2006, International journal of clinical practice.

[12]  S. Rennard,et al.  Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. , 2006, JAMA.

[13]  Rimonabant: new drug. Obesity: loss of a few kilos, many questions. , 2006, Prescrire international.

[14]  N. Rigotti,et al.  Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. , 2006, JAMA.

[15]  C. Lerman,et al.  Pharmacotherapy and pharmacogenetics of nicotine dependence. , 2005, The American journal of psychiatry.

[16]  G. Jennings,et al.  A therapeutic vaccine for nicotine dependence: preclinical efficacy, and phase I safety and immunogenicity , 2005, European journal of immunology.

[17]  S. T. Boyd,et al.  Rimonabant—A Selective CB1 Antagonist , 2005, The Annals of pharmacotherapy.

[18]  M. Weatherall,et al.  Efficacy of bupropion in the indigenous Maori population in New Zealand , 2005, Thorax.

[19]  K. Johnson,et al.  A placebo controlled randomized trial of the effects of phenylpropanolamine and nicotine gum on cessation rates and postcessation weight gain in women. , 2005, Addictive behaviors.

[20]  F. Lebargy,et al.  Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial. , 2004, Addiction.

[21]  J. Vestbo,et al.  A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[22]  L. Epstein,et al.  Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[23]  R. Sillett,et al.  The use of nicotine chewing gum as an aid to stopping smoking , 2004, Psychopharmacology.

[24]  S. Tonstad,et al.  A multicentre, randomized, double‐blind, placebo‐controlled, 1‐year study of bupropion SR for smoking cessation , 2003, Journal of internal medicine.

[25]  I Campbell,et al.  Nicotine replacement therapy in smoking cessation. , 2003, Thorax.

[26]  Z. Rumboldt,et al.  Smoking cessation with nicotine replacement therapy among health care workers: randomized double-blind study. , 2003, Croatian medical journal.

[27]  S. Hall,et al.  Psychological intervention and antidepressant treatment in smoking cessation. , 2002, Archives of general psychiatry.

[28]  M. Mayo,et al.  Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial. , 2002, JAMA.

[29]  B. Jamerson,et al.  Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: A randomized placebo‐controlled study , 2001, Clinical pharmacology and therapeutics.

[30]  P. Vokonas,et al.  Effects of nicotine gum dose by level of nicotine dependence. , 2000, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[31]  L. Stead,et al.  Anxiolytics and antidepressants for smoking cessation. , 2000, The Cochrane database of systematic reviews.

[32]  J R Hughes,et al.  Antidepressants for smoking cessation. , 2007, The Cochrane database of systematic reviews.

[33]  D. Schroeder,et al.  Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials. , 1999, American journal of public health.

[34]  J. P. Mckenna,et al.  Are higher doses of nicotine replacement more effective for smoking cessation? , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[35]  Aker,et al.  A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. , 1999, The New England journal of medicine.

[36]  A. Gulsvik,et al.  Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society. , 1999, The European respiratory journal.

[37]  J. Susman,et al.  Transdermal nicotine therapy and primary care. Importance of counseling, demographic, and participant selection factors on 1-year quit rates. The Nebraska Primary Practice Smoking Cessation Trial Group. , 1998, Archives of family medicine.

[38]  S. Fortmann,et al.  Nicotine patch and self-help video for cigarette smoking cessation. , 1997, Journal of consulting and clinical psychology.

[39]  D. Schroeder,et al.  A comparison of sustained-release bupropion and placebo for smoking cessation. , 1997, The New England journal of medicine.

[40]  S. Hall,et al.  Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. , 1996, Journal of consulting and clinical psychology.

[41]  G. Gustavsson,et al.  Importance of baseline cotinine plasma values in smoking cessation: results from a double-blind study with nicotine patch. , 1996, The European respiratory journal.

[42]  A. Forbes,et al.  Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers , 1995, BMJ.

[43]  K. Fagerström,et al.  Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program. , 1995, Chest.

[44]  G. Gustavsson,et al.  Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. , 1995, Preventive medicine.

[45]  G. Gustavsson,et al.  Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. , 1995, Addiction.

[46]  R. Richmond,et al.  The transdermal nicotine patch: results of a randomised placebo‐controlled trial , 1994, The Medical journal of Australia.

[47]  D. Mant,et al.  Randomised trial of nicotine patches in general practice: results at one year , 1994, BMJ.

[48]  R. Hurt,et al.  Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. , 1994, JAMA.

[49]  D. Wetter,et al.  Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. , 1994, Chest.

[50]  S. Leischow,et al.  Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. , 1993, Archives of internal medicine.

[51]  E. Levin,et al.  The nicotine patch in smoking cessation. A randomized trial with telephone counseling. , 1993, Archives of internal medicine.

[52]  D. Mant,et al.  Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. Imperial Cancer Research Fund General Practice Research Group. , 1993, BMJ.

[53]  J. Hughes,et al.  Transdermal Nicotine for Smoking Cessation. , 1993 .

[54]  A. Biglan,et al.  Transdermal Nicotine for Smoking Cessation: Six-Month Results From Two Multicenter Controlled Clinical Trials , 1991 .

[55]  P. Tønnesen,et al.  A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. , 1991, The New England journal of medicine.

[56]  S. Rennard,et al.  Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study. , 1991, Archives of internal medicine.

[57]  I. Sartori.  Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group. , 1991, JAMA.

[58]  S. Fortmann,et al.  Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. , 1990, Journal of consulting and clinical psychology.

[59]  T. Blöndal.  Controlled trial of nicotine polacrilex gum with supportive measures. , 1989, Archives of internal medicine.

[60]  J. Hughes,et al.  Nicotine vs placebo gum in general medical practice. , 1989, JAMA.

[61]  T. Abelin,et al.  Effectiveness of a transdermal nicotine system in smoking cessation studies. , 1989, Methods and findings in experimental and clinical pharmacology.

[62]  T. Abelin,et al.  CONTROLLED TRIAL OF TRANSDERMAL NICOTINE PATCH IN TOBACCO WITHDRAWAL , 1989, The Lancet.

[63]  S. Fortmann,et al.  Minimal contact treatment for smoking cessation. A placebo controlled trial of nicotine polacrilex and self-directed relapse prevention: initial results of the Stanford Stop Smoking Project. , 1988, JAMA.

[64]  P. Tønnesen,et al.  Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking. , 1988, The New England journal of medicine.

[65]  J. Punnotok,et al.  Smoking cessation through the use of nicotine chewing gum: a double-blind trial in Thailand. , 1988, Clinical therapeutics.

[66]  S. Hall,et al.  Nicotine gum and behavioral treatment: a placebo controlled trial. , 1987, Journal of consulting and clinical psychology.

[67]  I. Campbell,et al.  Stopping smoking. Do nicotine chewing-gum and postal encouragement add to doctors' advice. , 1987, The Practitioner.

[68]  A. Hjalmarson.  Effect of nicotine chewing gum in smoking cessation. A randomized, placebo-controlled, double-blind study. , 1984, JAMA.

[69]  N. Wald,et al.  Placebo controlled trial of nicotine chewing gum in general practice. , 1984, British medical journal.

[70]  M. Jarvik,et al.  Degree of addiction and effectiveness of nicotine gum therapy for smoking. , 1984, The American journal of psychiatry.

[71]  M. Jarvik,et al.  Nicotine gum in smoking cessation: a placebo-controlled, double-blind trial. , 1983, Addictive behaviors.

[72]  M. Raw,et al.  Randomised controlled trial of nicotine chewing-gum. , 1982, British medical journal.

[73]  Stewart Mj,et al.  A controlled trial of nicotine chewing gum in a smoking withdrawal clinic. , 1982 .

[74]  M. J. Stewart,et al.  A controlled trial of nicotine chewing gum in a smoking withdrawal clinic. , 1982, The Practitioner.